Table 1 Patient characteristics and laboratory findings
From: Serum zinc concentration in patients with myocardial infarction: a retrospective study
Overall cohort (n = 243) | Low zinc group (n = 111) | High zinc group (n = 132) | P | |
|---|---|---|---|---|
Age (years) | 67 ± 15 | 70 ± 16 | 65 ± 14 | 0.013 |
Male sex | 179 (74%) | 78 (70%) | 101 (77%) | 0.27 |
Body mass index (kg/m2) | 24.2 ± 3.9 | 23.8 ± 3.8 | 24.6 ± 4.1 | 0.12 |
Walking independently | 220/242 (91%) | 93/110 (85%) | 127/132 (96%) | 0.0017 |
Dyslipidemia | 138/243 (57%) | 56/111 (50%) | 82/132 (62%) | 0.067 |
Diabetes mellitus | 80/243 (33%) | 40/111 (36%) | 40/132 (30%) | 0.34 |
Hypertension | 147/243 (60%) | 74/111 (67%) | 73/132 (55%) | 0.071 |
Previous MI | 17/243 (7%) | 10/111 (9%) | 7/132 (5%) | 0.26 |
Previous HF admission | 1/243 (0.4%) | 0/111 (0%) | 1/132 (1%) | 0.36 |
Previous stroke | 23/243 (9%) | 13/111 (12%) | 10/132 (8%) | 0.27 |
Chronic hemodialysis | 1/243 (0.4%) | 1/111 (0.4%) | 0/132 (0%) | 0.27 |
Chronic AF | 17/243 (7%) | 10/111 (9%) | 7/132 (5%) | 0.26 |
Zinc (µg/dL) | 67 ± 14 | 55 ± 8 | 77 ± 10 | < 0.0001 |
Hemoglobin (g/dL) | 14.1 ± 2.0 | 13.4 ± 2.2 | 14.6 ± 1.7 | < 0.0001 |
Creatinine (mg/dL) | 0.91 ± 0.42 | 0.97 ± 0.57 | 0.88 ± 0.23 | 0.089 |
Creatine kinase (U/L) | 142 [80, 350] | 182 [95, 490] | 126 [75, 290] | 0.12 |
C-reactive protein (mg/dL) | 0.2 [0.1, 0.5] | 0.2 [0.1, 1.7] | 0.1 [0.1, 0.3] | < 0.0001 |
BS (mg/dL) | 172 ± 74 | 178 ± 82 | 166 ± 67 | 0.19 |
HbA1c (%) | 6.4 ± 1.4 | 6.5 ± 1.6 | 6.4 ± 1.2 | 0.53 |
Total cholesterol (mg/dL) | 204 ± 54 | 201 ± 62 | 207 ± 45 | 0.36 |
LDL-cholesterol (mg/dL) | 126 ± 42 | 122 ± 45 | 129 ± 40 | 0.26 |
HDL-cholesterol (mg/dL) | 46 ± 11 | 46 ± 11 | 47 ± 12 | 0.26 |
Triglyceride (mg/dL) | 125 [79, 183] | 104 [70, 171] | 132 [96, 203] | 0.93 |